GeneGlobe ID: UHS-005Z | Cat. No.: | QIAseq Multimodal Panels

QIAseq Multimodal Human Lung Cancer Panel

Kit containing ALL reagents (except indexes) for multimodal (DNA and RNA) sequencing

Select a variant to see the price

Product Specification

Target List

For DNA sequencing, covers all exons in all known transcripts of targeted genes based on the Human GRCh37 / hg19 genome build. For RNA sequencing, covers specific sides of specific exons of the targeted genes based on the Human GRCh38 genome build.

Non Small Cell Lung Cancers (NSCLC)
ADGRB3, ALK, AMER1, APC, ATM, BRAF, CDKN2A (P16INK4A), CTNNB1, EGFR (ERBB1), ERBB2 (HER-2, NEU), FGFR3, GRM8, HRAS, JAK2, KRAS, MET, MUC16, NF1, NFE2L2, NRAS, NTRK2, NTRK3, PDGFRA, PIK3CA (p110-alpha), PIK3CG, PKHD1, PTEN, RB1, RET, SMARCA4, STK11 (LKB1), TNFAIP3, TP53 (p53)
Small Cell Lung Cancers
ADGRB3, ALK, AMER1, ARID1A, ATM, CDKN2A (P16INK4A), CREBBP (CBP), CTNNB1, DDR2, EGFR (ERBB1), EPHA5, ERBB4, FBXO7, FBXW7, FGFR1, FHIT, GRM8, HRAS, KDR (VEGFR3), KIT (CD117), KMT2D, KRAS, LRP1B, MET, MUC16, MYC, NF1, NOTCH1, NTRK1, NTRK2, NTRK3, PIK3CA (p110-alpha), PIK3CG, PIK3R1 (p85-ALPHA), PKHD1, PTEN, PTPRD, RARB, RB1, RBM10, RET, RIT1, ROS1, RUNX1T1, SETD2, SMARCA4, TNFAIP3, TP53 (p53)
Carcinomas
Acinar Adenocarcinomas​
BRAF, EGFR (ERBB1), KRAS
Adenocarcinomas​
ADGRB3, AKT1, ALK, AMER1, APC, ARID1A, ATM, BAP1, BRAF, CDKN2A (P16INK4A), CDKN2B (p15INK4b), CREBBP (CBP), CTNNB1, DDR2, EGFR (ERBB1), EPHA5, ERBB2 (HER-2, NEU), ERBB4, FBXO7, FBXW7, FGFR1, FGFR2, FGFR3, FHIT, GRM8, HRAS, JAK2, KDR (VEGFR3), KEAP1, KIT (CD117), KMT2D, KRAS, LRP1B, MAP2K1, MDM2, MET, MGA, MLH1, MUC16, MYC, NF1, NFE2L2, NOTCH1, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA (p110-alpha), PIK3CG, PIK3R1 (p85-ALPHA), PIK3R2 (p85-BETA), PKHD1, PTEN, PTPRD, RARB, RASSF1, RB1, RBM10, RET, RIT1, ROS1, RUNX1T1, SETD2, SMAD4 (MADH4), SMARCA4, SOX2, STK11 (LKB1), TNFAIP3, TP53 (p53), TSC1, U2AF1
Bronchioalveolar Adenocarcinomas​
CDKN2A (P16INK4A), EGFR (ERBB1), ERBB2 (HER-2, NEU), KRAS, NF1, STK11 (LKB1), TP53 (p53)
Giant Cell Carcinomas​
EGFR (ERBB1)
Large Cell Carcinomas​
BRAF, CDKN2A (P16INK4A), DDR2, EGFR (ERBB1), EPHA5, FGFR1, FGFR3, HRAS, KEAP1, KRAS, NRAS, NTRK1, NTRK3, PIK3CA (p110-alpha), STK11 (LKB1), TP53 (p53)
Lymphoepithelioma-Like Carcinomas​
EGFR (ERBB1), TP53 (p53)
Micropapillary Adenocarcinomas​
BRAF, EGFR (ERBB1), KRAS
Mixed Adenosquamous Carcinomas​
EGFR (ERBB1), KRAS, PIK3CA (p110-alpha), STK11 (LKB1), TP53 (p53)
Mixed Small Cell Carcinomas-Adenocarcinomas​
CREBBP (CBP), DDR2, EGFR (ERBB1), TP53 (p53)
Mucoepidermoid Carcinomas​
EGFR (ERBB1)
Oncocytic Adenocarcinomas​
EGFR (ERBB1), KRAS
Other Carcinomas​
ARID1A, CTNNB1, HRAS, NRAS
Pleomorphic Carcinomas​
EGFR (ERBB1), KIT (CD117), KRAS, TP53 (p53)
Sarcomatoid Carcinomas​
EGFR (ERBB1), KRAS
Squamous Cell Carcinomas (SCC)​
ADGRB3, AKT1, ALK, AMER1, APC, ARID1A, ATM, BRAF, CDKN2A (P16INK4A), CDKN2B (p15INK4b), CREBBP (CBP), CTNNB1, DDR2, EGFR (ERBB1), EPHA5, ERBB2 (HER-2, NEU), ERBB4, FBXO7, FBXW7, FGFR1, FGFR2, FGFR3, FHIT, GRM8, HRAS, JAK2, KDR (VEGFR3), KEAP1, KIT (CD117), KMT2D, KRAS, LRP1B, MAP2K1, MDM2, MET, MGA, MLH1, MUC16, MYC, NF1, NFE2L2, NOTCH1, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA (p110-alpha), PIK3CG, PIK3R1 (p85-ALPHA), PIK3R2 (p85-BETA), PKHD1, PTEN, PTPRD, RARB, RB1, RBM10, RET, RIT1, ROS1, RUNX1T1, SETD2, SMAD4 (MADH4), SMARCA4, STK11 (LKB1), TNFAIP3, TP53 (p53), TSC1, U2AF1
Terminal Respiratory Unit Type Adenocarcinomas​
EGFR (ERBB1)
Undifferentiated Carcinomas​
EGFR (ERBB1), KRAS, MUC16, PKHD1, TP53 (p53)
Blastomas
CTNNB1, TP53 (p53)
Carcinoid-Endocrine Tumors
Atypical​
KRAS, PIK3CA (p110-alpha), TP53 (p53)
Typical​
PIK3CA (p110-alpha)
Carcinosarcomas
EGFR (ERBB1)
Other Cancer Subtypes
Hyperplasia​
EGFR (ERBB1), KRAS
Mucinous Proliferation​
KRAS
Neoplasms​
EGFR (ERBB1), KRAS
Acinar Adenocarcinomas
ALK, CD74, EML4, HIP1, KIF5B, ROS1, SDC4
Adenocarcinomas
ALK, BAIAP2L1, BCL11A, BRAF, CCDC6, CD74, CUX1, EML4, EZR, FGFR2, FGFR3, GCC2, GOPC, HIP1, HLA-DRB1, KIAA1217, KIF5B, KLC1, LRIG3, MET, MPRIP, NCOA4, NRG1 (HGL), NTRK1, NTRK2, PBX1, RET, ROS1, SDC4, SLC34A2, SND1, STARD3NL, STRN, TACC3, TCF3, TFG, TPM3, TPR, TRIM33
Bronchioloalveolar Adenocarcinomas
ALK, EML4, KLC1, PBX1, ROS1, SDC4, TCF3
Inflammatory Myofibroblastic Tumors
ALK, CD74, EML4, EZR, GOPC, LRIG3, ROS1, SDC4, SLC34A2, TPM3
Invasive Mucinous Adenocarcinomas
ALK, CD74, EML4, NRG1 (HGL), SLC3A2
Mixed Adenosquamous Carcinomas
ALK, EML4, KIF5B, RET
Mucoepidermoid Carcinomas
ALK, CRTC1, EML4, MAML2
Non-Small Cell Carcinomas
ALK, BCL11A, CCDC6, CD74, CUX1, EGFR (ERBB1), EML4, EZR, GCC2, GOPC, HIP1, KIAA1217, KIF5B, KLC1, LRIG3, NCOA4, RET, ROS1, SDC4, SLC34A2, STRN, TFG, TPM3, TPR, TRIM33
Non-Small Cell Lung Cancers (NSCLC)
ALK, BAG4, BAIAP2L1, BCL11A, CCDC6, CD74, CLIP4, CUX1, DNAH5, EGFR (ERBB1), EML4, ETV6, EZR, FER, FGFR1, FGFR3, GCC2, GLRX5, GOPC, HIP1, HLA-DRB1, IRF2BP2, KIAA1217, KIF5B, KLC1, LRIG3, MAN2A1, MET, MPRIP, NCOA4, NRG1 (HGL), NTRK1, NTRK3, RAD51, RET, ROS1, RUNX1 (AML1), SDC4, SLC34A2, SLC3A2, SQSTM1, STRN, TACC3, TFG, TPM3, TPR, TRA2B, TRIM33, VSNL1
Squamous Cell Carcinomas (SCC)
ALK, BAIAP2L1, CD74, EML4, FGFR2, FGFR3, HIP1, KIF5B, NRG1 (HGL), RET, TACC3
Other Carcinomas
ALK, BRD4, EML4, NUTM1
Other Lung Cancers
ARL17A, BAG4, BAIAP2L1, CCDC6, CD74, CUX1, EZR, FGFR1, FGFR3, GOPC, IRF2BP2, KANSL1, KIAA1217, KIF5B, LRIG3, MPRIP, NCOA4, NRG1 (HGL), NTRK1, NUTM1, PTPRK, RET, ROS1, RSPO3, SDC4, SLC34A2, SLC3A2, SQSTM1, TACC3, TPM3, TPR, TRIM33, WHSC1L1

Product Resources

Detailed Target List for each Analyte
File Size: 17.94 KBLanguage: English

Resources

Brochures & Guides (4)
State-of-the-art technologies to fast-track and streamline NGS workflows
QIAseq Multimodal Analytical Technology
QIAseq Multimodal: The power of one
Supplementary Files (1)
List of gene targets for QIAseq Pan-cancer Multimodal Panel
Safety Data Sheets (1)
Certificates of Analysis (1)
Introducing the QIAseq Multimodal Human Lung Cancer Panel, a cutting-edge addition to our QIAseq Multimodal Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Multimodal Human Lung Cancer Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Multimodal Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Multimodal Human Lung Cancer Panel and elevate your work to new heights.